Influence of Hormone Therapy on Heart Attack Incidence in Men Undergoing Prostate Brachytherapy

The purpose of this study is to review cause of death in patients undergoing prostate brachytherapy at a single institution. Furthermore, we are analyzing patients undergoing androgen deprivation therapy and whether or not this contributed to cardiovascular deaths, specifically myocardial infarction.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Prostate Cancer Cardiovascular Death Genital Diseases Genital Diseases, Male Genital Neoplasms, Male Male Urogenital Diseases Neoplasms Neoplasms by Site Prostatic Diseases Prostatic Neoplasms Urogenital Diseases Urogenital Neoplasms

Sex eligibility

Male

Study type

Observational

Primary location

Chicago Prostate Center

Westmont, Illinois, 60559, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Deceased anytime after prostate brachytherapy treatment

Exclusion criteria

Patients whose cause of death was unable to be determined

Treatment and study plan

No intervention was required

Other

Death records were reviewed, therefore, there was no intervention

Other names: Death records were reviewed, therefore, there was no intervention

Sponsors and collaborators

Lead sponsor

Prostate Cancer Foundation of Chicago

Other

Registry information

Official study title

Influence of Androgen Suppression Therapy for Prostate Cancer on the Timing and Onset of Fatal Myocardial Infarctions in Men Undergoing Prostate Brachytherapy

Important dates

First posted: Apr 2, 2008
Registry last updated: Apr 2, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed